VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price fell 7.4% during mid-day trading on Wednesday . The company traded as low as C$0.12 and last traded at C$0.13. 270,069 shares traded hands during trading, an increase of 21% from the average session volume of 222,974 shares. The stock had previously closed at C$0.14.
The stock has a market capitalization of $8.36 million and a PE ratio of -2.64.
In other VentriPoint Diagnostics news, Director George Adams sold 1,500,000 shares of the stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of C$0.16, for a total transaction of C$232,500.00. Following the transaction, the director now owns 65,999 shares in the company, valued at C$10,229.85.
VentriPoint Diagnostics Company Profile (CVE:VPT)
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers.
Read More: Liquidity
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.